4
results
for author:"Atkins T."
in Literature Citations
| A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. Haque A., Chu K., Easton A., Stevens M.P., Galyov E.E., Atkins T., Titball R., Bancroft G.J. J. Infect. Dis. 194:1241-1248(2006) · UniProtKB (2) |
| Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Holden M.T.G., Titball R.W., Peacock S.J., Cerdeno-Tarraga A.-M., Atkins T., Crossman L.C., Pitt T., Churcher C., Mungall K.L., Bentley S.D. et al. Proc. Natl. Acad. Sci. U.S.A. 101:14240-14245(2004) · UniProtKB (5,717) |
| Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Stevens M.P., Haque A., Atkins T., Hill J., Wood M.W., Easton A., Nelson M., Underwood-Fowler C., Titball R.W., Bancroft G.J. et al. Microbiology 150:2669-2676(2004) · UniProtKB (3) |
| Age influences resistance of Caenorhabditis elegans to killing by pathogenic bacteria. Laws T.R., Harding S.V., Smith M.P., Atkins T.P., Titball R.W. FEMS Microbiol. Lett. 234:281-287(2004) · Mapped (1) |
